Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
暂无分享,去创建一个
Bernd Kirchhof | John Rudge | N. Mitsiades | B. Kirchhof | G. Yancopoulos | S. Wiegand | A. Joussen | A. Adamis | V. Poulaki | George D Yancopoulos | Vassiliki Poulaki | J. Rudge | Anthony P Adamis | Wenying Qin | Antonia M Joussen | Stanley J Wiegand | Nicholas Mitsiades | Wenying Qin
[1] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[2] K Miyamoto,et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. , 2000, Investigative ophthalmology & visual science.
[3] T. Grosser,et al. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. , 2000, Thrombosis research.
[4] L. Aiello,et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Jain,et al. During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.
[6] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[7] R. Maciewicz,et al. Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis , 2000, Laboratory Investigation.
[8] H. Ueno,et al. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration , 2000, Gene Therapy.
[9] K Miyamoto,et al. VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.
[10] R K Jain,et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.
[11] Z. Radisavljevic,et al. Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[12] K. Nakagawa,et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[13] D. Lefer,et al. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.
[14] S. Kondo,et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. , 1996, Biochemical and biophysical research communications.
[15] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[16] D. Connolly,et al. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. , 1993, Kidney international.
[17] J. El Benna,et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. , 1997, Blood.
[18] S. Rafii,et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] E S Gragoudas,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[20] M. Lauritzen,et al. Nitric Oxide Synthase Activity and Expression in Experimental Diabetic Neuropathy , 2000, Journal of neuropathology and experimental neurology.
[21] G. Schmid-Schönbein,et al. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.
[22] J. Cunha-Vaz,et al. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. , 2000, Nitric oxide : biology and chemistry.
[23] T. Horiuchi,et al. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. , 1997, American journal of respiratory cell and molecular biology.
[24] Peitan Liu,et al. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. , 1998, American journal of physiology. Heart and circulatory physiology.
[25] D. Connolly,et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.
[26] K Miyamoto,et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.
[27] S. Soker,et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.